Predicting response to neoadjuvant hormonal therapy and prognostic outcomes in high-risk prostate cancer using
Hai Zhou1, Zhi-Yu Qian1, Zhi-Hao Chen1
1Department of Urology, Fudan University Affiliated Huadong Hospital, Shanghai, China.
BMC Cancer
|April 29, 2026
Abstract
No abstract available in PubMed .


